[14C]Arachidonic acid incubated with human neutrophils was esterified into phospholipids and triglycerides. Stimulation of these labeled neutrophils with ionophore A23187 (2 microM) results in release of [14C]arachidonate from phospholipid and its metabolism to prostaglandin E2 and 5-hydroxy-6,8,11,14-eicosatetraenoic acid (5-HETE), a lipoxygenase product. The released arachidonate is also metabolized to a polar lipid of unknown composition here disignated compound A. 5-HETE was found to be released into the medium and then taken up again by the cells. To determine its metabolic fate, [14C]5-HETE was prepared biosynthetically, purified, and incubated with stimulated, unlabeled neutrophils. Most of the radioactivity entered the cells and was esterified into phospholipids and triglycerides. The radiolabeled complex lipids were saponified, and the released fatty acids cochromatographed with authentic 5-HETE. The esterification of 5-HETE, a hydroxylated fatty acid, into membrane phospholipids may be an example of a more generalized mechanism for altering membrane characteristics. 
INTRODUCTION
Although the metabolism of arachidonic acid has been less thoroughly studied in neutrophils than in many other cell types, there is evidence that it is metabolized through both the cyclooxygenase and lipoxygenase
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Receivedfor publication 13 April 1979 and in revisedform 2 July 1979. pathways. Both prostaglandin E2 (PGE2)' and thromboxane B2 (TXB2) have been reported to be formed in animal and human neutrophils (1-3); 5-hydroxy-6,8,11,14-eicosatetraenoic acid (5-HETE), a presumed product of the lipoxygenase pathway, has been identified in rabbit neutrophils (4) , but evidence that its formation can be modulated by physiologic and pharmacologic stimuli of neutrophil function has not been presented, and its functional role is presently undefined. In a recent abstract we reported (5) that several soluble or insoluble stimuli of oxidative metabolism in human neutrophils (A23187, the divalent cation ionophore, fluoride, zymosan particles) stimulated the conversion of radioactive arachidonic acid to a metabolite cochromatographing with 5-HETE in these cells. In this paper we characterize the response to the most effective of these 5-HETE generating agents, A23187. In addition, evidence is presented that newly synthesized 5-HETE is incorporated into phospholipids and triglycerides, as well as released into the medium. Purification of cells. Purified human neutrophils and platelets were prepared from heparinized blood by dextran sedimentation followed by isopycnic centrifugation using a Ficoll-Hypaque gradient (Pharmacia Fine Chemicals, Piscataway, N. J. [6] ). Blood donors had taken no medication for at least 2 wk. Neutrophil preparations were monitored by phase microscopy and Giemsa staining and contained <1 platelet/neutrophil. More than 98% of the nucleated cells were neutrophils. In selected experiments platelets were further depleted by defibrinating the blood (7) . In this case the purified neutrophil preparation had a neutrophil to platelet ratio of 10:1 to 100:1. Defibrinated blood was used only in selected experiments because of the great loss of neutrophils when this technique is used. To prepare purified platelets, platelets were separated from nucleated cells during the routine Ficoll-Hypaque purification of lymphocytes by serial low-speed centrifugation (6) . Platelet preparations contained <1 nucleated cell/100 platelets. Rabbit peritoneal neutrophils were prepared by the method of Borgeat et al. (4) from glycogen-injected animals. More than 95% of the recovered peritoneal cells were neutrophils.
Incubation conditions. With the exception of a portion of the experiments evaluating platelet contamination, all experiments were performed using cells labeled with radioactive arachidonic acid. Neutrophils (1 x 107/ml) were incubated in mast cell medium (MCM), a balanced salt medium, for 1 h in the presence of [1-'4C]arachidonic acid (1 ,uM) (1.1 x 105 cpm/ml). This medium has been used previously in our laboratory in studies ofmast cells (8 (12) . 5-HETE standard prepared from rabbit peritoneal neutrophils comigrated with an apparently identical product in human neutrophil in solvent systems I, II, and III. Methyl esters of the rabbit and human 5-HETE were prepared with diazomethane; the methyl esters comigrated in solvent system IV. 5-HETE was further identified by gas-liquid chromatography-mass spectroscopy of the trimethylsilyl ether of the methyl ester. Analysis was done on a Finnegan 300 (Finnegan Corp., Sunnyvale, Calif.) system using an OV-101 column. Prominent peaks were found at methyl ester 255, 305, and 406, corresponding to the known fragmentation pattern of the trimethylsilyl ether derivative of 5 (2 ,uM) for 15 min. The incubation medium was extracted as described above, and the lipids were separated by TLC in solvent system III. The labeled 5-HETE band was again identified by autoradiography, scraped, and eluted; The purified 5 [I4C]arachidonic acid used as a precursor and neglecting dilution by endogenous, unlabeled arachidonic acid) was incubated with 6 x 107 neutrophils in 6 ml of MCM in the presence of 2 ,uM A23187 at 37°C for 30 min. After centrifugation of the incubation mixtures in a Beckman Microfuge for 10 s, the supernate and cell pellet were separated and extracted by the usual method. The lipids recovered were then chromatographed in solvent system I and in a two-dimensional TLC system (14) to separate the individual phospholipid classes (first dimension-chloroform:methanol:ammonium hydroxide: water [65: 35:2.5:2.5]; second dimension-chloroform:acetone:methanol: acetic acid:water [50:22:9:10:5]). The radiolabeled products were identified by autoradiography and compared with unlabeled standards visualized with I2 vapor. To determine whether the radiolabel in phospholipid and triglycerides was esterified 5-HETE, the phospholipid and triglyceride bands were scraped and eluted, and the lipids recovered were subjected to transesterification in anhydrous methanol containing 0.2 N NaOH (15) . The liberated fatty acid methyl esters were then chromatographed using solvent system IV and compared with known standards.
RESULTS
Labeling of cells. The effects of A23187 on the metabolism of arachidonic acid were studied in previously labeled neutrophils. To obtain labeled cells, neutrophils were incubated with [1-_4C]arachidonate (1 ,uM) for 1 h and then washed repeatedly with medium.
In a representative experiment, extraction and chromatography ofthese cells showed that 57% of the incorporated radiolabel was in triglyceride and 43% was in phospholipid. In this and other experiments, essentially none of the radiolabel remained as free arachidonate or was metabolized to 5-HETE or the other metabolites produced when A23187 was present. To demonstrate that the radiolabel in phospholipid and triglyceride was in fact esterified arachidonate, the phospholipid and triglyceride bands were scraped, eluted, and subjected to transesterification (15) . Virtually all of the released radiolabeled fatty acid chromatographed as fatty acid methyl esters in several chromatographic systems, and therefore presumably represents free arachidonic acid.
Characterization of metabolites in neutrophils stimulated with A23187. In prelabeled neutrophils prepared in the usual way and therefore significantly contaminated with platelets, A23187 (2 ,uM, 15 min at 37°C) stimulated formation of at least five known metabolites of arachidonic acid not seen in its absence. The identification of these products was based on their identical behavior to known chromatographic standards in the four solvent systems described above. These metabolites were deternined to be 5-HETE, 12-HETE, TXB2, PGE2, and 12-L-hydroxy-5,8,10-heptadecatrienoic acid. In addition, an unknown metabolite was formed which we designate as compound A. Assessment of the role of platelet contamination. Because a number of these products are formed in platelets, and because platelets metabolize arachidonic acid rapidly, the role of platelet contamination of our neutrophil preparations was assessed. Isolated platelets, ordinary neutrophil preparations, and neutrophils purified further by defibrination containing as few as 1 platelet/100 neutrophils were studied in the presence and absence ofA23187 (Table I ). Because ofdifferences in prelabeling efficiency between platelets and neutrophils, most of these experiments involved unlabeled cells incubated simultaneously with exogenous [14C]-arachidonic acid and either buffer (with DMSO) or A23187. However, in three experiments with prelabeled platelets and neutrophils, much the same results were obtained. Similar conclusions were drawn from studies with defined neutrophil/platelet mixtures prepared by adding various numbers of platelets back to plateletpoor neutrophils. Although both platelets and neutrophils make PGE2, it appeared that under our ordinary labeling conditions (with neutrophils prepared inr the usual way) >90% ofthe labeled PGE2 was from neutrophils. All of the 5-HETE and compound A synthesis could be attributed to neutrophils. Neutrophils also appeared to make very small quantities of TXB2 (and therefore presumably thromboxane A2), agreeing with a recent report (3) . Even at relatively low platelet:neutrophil ratios, however, most of the TXB2 probably comes from the platelets. Because TXB2 is such a quantitatively minor arachidonate metabolite in human neutrophils, and because of possible problems in interpretation in attempting to distinguish platelet-derived TXB2, we have not included it in the tubular presentation of our data.
Further characterization of the A23187 response in the presence and absence ofBSA. Because BSA binds fatty acids with relatively high affinity, it serves as a trap to diminish the reuptake of released arachidonic (2 ,uM) in MCM with 0.1% BSA. In the cell pellet (Fig. 1A) , the percent ofthe total radiolabel in triglycerides declined very slightly during stimulation, whereas the percent in phospholipid declined markedly, indicating release of free arachidonate. The released arachidonate diffused into the medium and was trapped or was metabolized intracellularly to metabolites which subsequently entered the medium. After 30 min ofstimulation, the supernates contained =11% of the original radiolabel as arachidonate, 6% as PGE2, 3% as 5-HETE, and 1.4% as compound A (Fig. 1B) . All ofthese products accumulated rapidly for the first 5 min and more slowly thereafter.
When there was no albumin in the medium, significant amounts ofarachidonate, 5-HETE, and compound A were apparently associated with the cells (Fig. 1C) . On the other hand, all of the PGE2 was released into the medium whether albumin was present or not (Fig.  1D) . With no albumin in the medium, the levels of 5-HETE in the supernate rose for 2 min and then fell sharply. By contrast, when albumin was present in the medium, the levels of5-HETE rose for 15 min and then leveled off. Despite the decline in 5-HETE in the albumin-free medium, there was no corresponding rise in the level of intracellular 5-HETE. However, as is shown below, the fall in 5-HETE can be explained by its subsequent incorporation into intracellular lipids.
Without albumin in the medium, the percent of total radiolabel in phospholipid remained higher during stimulation than when albumin was present, presumably because the released fatty acid was more readily available for reincorporation into cellular lipids (see below). Dose-response curves for the stimulation of the incorporation of radiolabel into 5-HETE by A23187 are shown in Fig. 2 . As the level of radioactivity in 5-HETE reached a peak at 2 min in the absence of BSA and at 15 min in the presence ofBSA, these incubation times are shown. The two curves were almost identical, with maximal stimulation at 2 AM A23187.
The ionophore dose-response curves for stimulation of compound A and PGE2 formation were almost identical to the curve for 5-HETE (not shown) as might be expected if the rate-limiting step for all three reactions is the availability of free arachidonate. Under physiologic conditions, the level of intracellular and extracellular nonesterified arachidonic acid is extremely low, and the rate-limiting step in the synthesis of prostaglandins and other metabolites is generally thought to be the release of arachidonic acid from membrane lipids (16) . In accordance with this postulated mechanism, a similar dose-response curve was seen for release of arachidonate radioactivity from cellular phospholipid (Fig. 2) . Fig. 3 depicts the effect of calcium in the medium on release of arachidonate from phospholipid and on 5-HETE production. With no calcium in the medium, there was no release of arachidonate from phospholipid, and no 5-HETE was produced. 5-HETE production rose rapidly with increases in Ca2+ concentration up to 0.5 mM Ca2+ and then leveled off. The Ca2+ concentration for arachidonic acid release was very similar, although not identical, to a maximal response at 1 mM Ca2 . In the absence of A23187, use of Ca2+ concentrations as high as 1.5 mM had no effect on either process.
Metabolism of exogenous 5-HETE by neutrophils. In the experiments shown in Fig. 1B and D, different time-courses for 5-HETE accumulation were seen. One possible explanation is that albumin traps 5-HETE just as it does arachidonic acid, and that when no albumin is present, 5-HETE reenters the cell and is metabolized. To investigate this possibility, purified [1-14C] 5-HETE was incubated with neutrophils in albumin-free medium, with and without A23187. The cells and medium were extracted and chromatographed separately (Table II) . Most of the [1-_4C]5-HETE was taken up by the cells both in the presence and absence of A23187. In the unstimulated cells most of the label comigrated with triglycerides; in stimulated cells most comigrated with phospholipids. Although the level of available radioactivity in phosphatidic acid was substantially lower, incorporation of radioactivity into phosphatidic acid could also be demonstrated.
To determine whether the radiolabel in triglycerides and phospholipids represented FIGURE 2 Dose-response curve for A23187 stimulation of incorporation of radiolabel in 5-HETE using "endogenous" arachidonic acid. Incubation conditions as in Fig. 1A droxyl group were enzymatically removed from 5-HETE without steric rearrangement), the triglycerides and phospholipids were isolated, transesterified, and the products rechromatographed in solvent system IV. In each case the transesterification was at least 80% complete, and 95% of the released radiolabel rechromatographed with 5-HETE in striking contrast to the transesterified lipids from cells prelabeled with [54C]arachidonic acid. Thus, lipid recovered by transesterification apparently retains its original 5-hydroxyl group, suggesting strongly that 5-HETE is being incorporated as such into cellular lipids. However, because the steric configuration of the double bonds in the recovered lipid has not yet been evaluated, the possibility of isomerization cannot be excluded.
Cytotoxicity studies. To evaluate the possible role ofcytotoxicity in the response ofneutrophils to A23187, the cells were exposed to 0.4, 1, 2, and 10 ,uM A23187 for 10 min at 37°C in the presence and absence of BSA (the same conditions as used for the experiments in Fig. 3 ; see above). Under all conditions 98% of the cells continued to exclude trypan blue (the same percent as in the controls), and phagocytosis of zymosan particles was not altered.
DISCUSSION
This study demonstrates that when labeled human neutrophils are stimulated with A23187, they transform arachidonic acid into 5-HETE, a hydroxylated fatty acid produced by neutrophils but not by platelets. Transformation of arachidonate into PGE2 and a relatively polar lipid of unknown composition, here designated compound A, is also observed. 5-HETE was originally reported by Borgeat et al. (4) to be a major arachidonate metabolite in rabbit peritoneal neutrophils. These cells were obtained from the peritoneal cavity of rabbits injected in the same site with glycogen to promote the accumulation of a cellular exudate. Even though we also were able to demonstrate the conversion oflabeled arachidonic acid to 5-HETE in rabbit neutrophils (also obtained using the glycogen procedure), was not labeled to a significant extent by resting human peripheral blood neutrophils under identical incubation conditions. Moreover, no labeling occurred during the 1-h preincubation with [14C]arachidonic acid, which was routinely used in labeling the cells. By contrast, in the presence of 2 ,M A23187 4% of the original radioactivity was released as 5-HETE over a period of 15 min (Fig. 1B) . Thus, even though both rabbit and human neutrophils make 5-HETE, human neutrophils only express this capability when an exogenous stimulant such as A23187 is present. Although variations between species might account for these differences, it seems more likely that the 5-HETE production by rabbit neutrophils is a reflection of the in vivo stimulation by glycogen, and that, as in human neutrophils, 5-HETE is not normally produced unless the cells have first been metabolically activated.
In considering the possible mechanism ofthe A23187 stimulation, it is noteworthy that A23187 has a similar dose-response curve for stimulation of 5-HETE, PGE2, free arachidonate, and compound A formation, and that all of these responses are Ca2+ dependent. Taken together with the rapid fall in radioactivity in phospholipids after A23187 is added, this suggests that A23187 is exerting its primary action by releasing arachidonic acid esterified to phospholipids. The availability of free arachidonate is normally regarded as the rate-limiting step in prostaglandin and hydroxylated fatty acid biosynthesis (15) . There is an apparent parallel with recent results in platelets prelabeled with arachidonic acid in which the divalent cation ionophore A23187 also releases arachidonic acid from phospholipid, and in which thromboxane and 12-HETE labeling are concurrently increased (17) .
Although the significance of the increases in arachidonate metabolism is not clear, it should be noted that A23187 mimics many of the effects of physiologic stimuli such as serum-coated zymosan particles in human neutrophils. Both ionophore and zymosan particles activate the respiratory burst, producing increases in oxygen consumption and hexose monophosphate shunt activity (18, 19) . Moreover, work in progress indicates that zymosan particles produce effects apparently identical to those of A23187 on arachidonate metabolism in these cells with increased labeling of 5-HETE, PGE2, and compound A (5) (manuscript in preparation), and Zurier has previously reported that PGE2 synthesis is stimulated in human neutrophils by zymosan (1). Because the mechanism by which the respiratory burst is activated is not known, it may be significant that 5-hydroperoxy-eicosatetraenoic acid, the presumed intermediate in the conversion of arachidonic acid to 5-HETE by the lipoxygenase, is an alkyl hydroperoxide (4). Even though 5-hydroperoxy-arachidonic acid has not yet been directly demonstrated in plant or animal cells, all of the lipoxygenases that have been carefully studied to date produce hydroperoxy fatty acids as their primary products (20) , and the presence of the corresponding hydroxy fatty acids is indicative of further metabolic conversion. Long chain alkyl peroxides are known substrates for glutathione peroxidase, an enzyme reported to be present in both animal and human neutrophils (21, 22) . The availability of 5-hydroperoxy-arachidonic acid provides another possible substrate for this enzyme and could account for part of the increase in shunt activity. These findings in regard to lipoxygenase activation may also have significance for slow-reacting substance and lysosomal enzyme release and chemiluminescence in activated neutrophils.
The incorporation of 5-HETE into cell membranes was an unexpected finding. It appears that a series of metabolic conversions is occurring in which: (a) arachidonic acid and other fatty acids are released from phospholipid, presumably at least in part by activation of phospholipase A2; (b) arachidonic acid is converted to 5-HETE by lipoxygenase; (c) 5-HETE is incorporated into membrane phospholipids and triglycerides (Fig. 4) . In this connection Smolen and Shohet (23) reported 5 yr ago that neutrophil phagocytic vesicles contained much less arachidonic acid in their-phospholipids than either the lysosomes or plasma membranes from which they were presumably derived. At the time of their study, had not yet been described. Substantial amounts of triglyceride and phosphatidic acid are also labeled in A23187-stimulated leukocytes, and the amounts of label are considerably higher in phosphatidylethanolamine and phosphatidylcholine than in phosphatidylinoistol. This suggests that most of the incorporation involves more than a simple exchange of fatty acid molecules in phospholipids, and that at least some de novo synthesis of phosphatidic acid and modification of head groups is occurring. Because the incorporation of 5-HETE into lipid is much greater when albumin is absent from the medium, its physiologic
